ERBB2 and breast carcinoma: The diagnosis, treatment, and prognosis of patients with breast cancer are closely related to their molecular subtypes, which are classified by the expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and proliferation marker Ki67.